Consolidated figures · ₹ crore
| ₹ Cr | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| 321 | 447 | 580 | 533 | 431 | 460 | 564 | 558 | |
| COGS | 269 | 307 | 358 | 432 | 343 | 306 | 346 | 459 |
| Gross profit | 52 | 140 | 222 | 102 | 88 | 154 | 218 | 99 |
| 85 | 104 | 110 | 96 | 96 | 111 | 132 | 98 | |
| -33 | 36 | 112 | 6 | -8 | 43 | 86 | 1 | |
| OPM % | -10.2% | 8.1% | 19.4% | 1.1% | -1.8% | 9.4% | 15.3% | 0.1% |
| Depreciation | 12 | 12 | 13 | 14 | 14 | 14 | 14 | 14 |
| Interest | 20 | 19 | 13 | 15 | 12 | 10 | 11 | 14 |
| 1 | 4 | 9 | 1 | -23 | -6 | 9 | 2 | |
| Profit before tax | -64 | 8 | 96 | -22 | -57 | 13 | 70 | -26 |
| Tax | 11 | 3 | 24 | -6 | -15 | 5 | 17 | -7 |
| Tax % | 17% | 32% | 24.9% | -28.2% | -26.9% | 38.8% | 24.7% | -25.3% |
| -75 | 6 | 72 | -16 | -42 | 8 | 53 | -19 | |
| PAT margin % | -23.4% | 1.3% | 12.4% | -3% | -9.7% | 1.8% | 9.4% | -3.5% |
| EPS (₹) | -17.9 | 1.3 | 14.1 | -3.1 | -8.1 | 1.6 | 10.3 | -3.8 |
| Results filing | — | — | — | Results filing for Jun 2025 | Results filing for Sep 2025 | Results filing for Dec 2025 | Results filing for Mar 2026 | Results filing for Jun 2026 |
| vs same quarter last year | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue YoY % | — | — | — | — | +34.2% | +2.8% | -2.7% | +4.6% |
| PAT YoY % | — | — | — | — |
As reported in NSE results XBRL. Segment result is before tax and finance costs.
Latest reported period · 30 Jun 2026 · ₹ crore
| Segment | Revenue | Result | Assets | Liabilities | Capital employed |
|---|---|---|---|---|---|
| Sugar | 253.41 | -16.04 | 598.4 | 712.58 | — |
| Bio based Chemicals | 168.67 | 15.83 | 540.52 | 202.12 | 338.4 |
| — |
| +43.2% |
| -26.5% |
| — |
| Distlliery | 155.48 | -1.77 | 567.87 | 80.03 | 487.84 |
| Cogeneration | 24.49 | -7.98 | 86.81 | 12.86 | 73.95 |
| Unallocated | 11.26 | -1.96 | 0 | 0 | — |
₹ crore by quarter